Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms
Shares of Vertex Pharmaceuticals Inc.
VRTX,
inched 0.31% higher to $181.90 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index
SPX,
rising 1.71% to 4,438.26 and the Dow Jones Industrial Average
DJIA,
rising 1.56% to 34,912.56. This was the stock’s fourth consecutive day of gains. Vertex Pharmaceuticals Inc. closed $61.09 short of its 52-week high ($242.99), which the company reached on January 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson
JNJ,
rose 0.57% to $160.11, Merck & Co. Inc.
MRK,
fell 0.79% to $78.33, and AbbVie Inc.
ABBV,
rose 1.57% to $108.91. Trading volume (1.9 M) eclipsed its 50-day average volume of 1.6 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Read More: Vertex Pharmaceuticals Inc. stock rises Thursday, still underperforms